Advance Search
GUO Shaomei. Efficacy and safety of recombinant human erythropoietin-alpha (rHuEPO) in the treatment of cancer anemia[J]. Journal of Clinical Medicine in Practice, 2012, (19): 110-112.
Citation: GUO Shaomei. Efficacy and safety of recombinant human erythropoietin-alpha (rHuEPO) in the treatment of cancer anemia[J]. Journal of Clinical Medicine in Practice, 2012, (19): 110-112.
shu

Efficacy and safety of recombinant human erythropoietin-alpha (rHuEPO) in the treatment of cancer anemia

More Information
  • Published Date: January 15, 2013
    Graphical Abstract
    • Abstract
    • FullText(HTML)
    • References (11)
  • 黎莉, 徐从高, 王秀问. 重组人促红细胞生成素治疗癌性贫血的临床研究 [J]. 山东大学学报（医学版）, 2004(6):684.doi: 10.3969/j.issn.1671-7554.2004.06.019.
    邓燕明, 王巍, 张华. 重组人红细胞生成素治疗癌性贫血的临床观察 [J]. 南方医科大学学报, 2007(7):1102.doi: 10.3321/j.issn:1673-4254.2007.07.049.
    Hasegawa T, Bragg-Gresham J L, Pisoni R L. Changes in anemia management and hemoglobin levels following revision of a bundling policy to incorporaterecombinant human erythropoietin [J]. Kidney International, 2011(3):340.
    马沐雅, 杨泽敏, 冯玫. 重组人促红细胞生成素对卵巢癌细胞EPOR表达及肿瘤增殖的影响 [J]. 中国现代药物应用, 2008(6):11.doi: 10.3969/j.issn.1673-9523.2008.06.005.
    Shin S K, Pack S P, Oh J G. Anti-erythropoietin and anti-thrombopoietin antibodies induced after administration of recombinant human erythropoietin [J]. International Journal of Immunopharmacology, 2011, (12):2237.
    刘莉, 丁乾, 戴小芳. 促红细胞生成素冲击方法治疗化疗相关贫血的临床研究 [J]. 临床血液学杂志, 2007(1):31.doi: 10.3969/j.issn.1004-2806.2007.01.011.
    Katsanos K H, Tatsioni A, Natsi D. Recombinant human erythropoietin in patients with inflammatory bowel disease and refractoryanemia:A 15-year single center experience [J]. J Crohns Colitis, 2012(1):56.
    Trkulja V. Treating anemia associated with chronic renal failure with erythropoicsis stimulators:recombinant human erythropoietin might be the best among the available choices [J]. Medical Hypotheses, 2012(1):157.
    李梅, 吕跃, 陈晓勤. 促红细胞生成素及其受体在恶性肿瘤组织中的表达及功能的研究进展 [J]. 癌症, 2008(6):667.doi: 10.3321/j.issn:1000-467X.2008.06.022.
    陈蕊, 魏丛军, 高波. 重组人促红细胞生成素对尿毒症患者血清瘦素的影响 [J]. 实用临床医药杂志, 2007(9):121.doi: 10.3969/j.issn.1672-2353.2007.09.049.
    Abhold E, Rahimy E, Wang-Rodriguez J. Recombinant human erythropoietin promotes the acquisition of a malignant phenotype in head and neck squamous cell carcinoma cell lines in vitro [J]. BMC Res Notes, 2011(1):553.
    • Related Articles

  • Related Articles

    [1]YAO Binbin, SHEN Yan, YANG Hongli, FENG Sujuan, HUANG Huaxing, ZHU Xueling, SHEN Lianglan. Impact of serum cystatin C and hypersensitivity C-reactive protein on the 3-year survival of patients undergoing maintenance hemodialysis[J]. Journal of Clinical Medicine in Practice, 2024, 28(18): 68-75, 80. DOI: 10.7619/jcmp.20240283
    [2]QIU Yuan, LI Li, ZENG Laixing. Changes of C reactive protein and serum procalcitoninin patients with severe acute pancreatitis[J]. Journal of Clinical Medicine in Practice, 2019, 23(12): 62-64. DOI: 10.7619/jcmp.201912018
    [3]MENG Xiangzhong, WEI Feng, WANG Na, SHI Zhenhua, DING Dongrui. Clinical analysis of plasma procalcitonin and C-reactive protein levels in 65 patients with septic shock[J]. Journal of Clinical Medicine in Practice, 2018, (3): 120-122. DOI: 10.7619/jcmp.201803035
    [4]LIU Li, LIU Mingxin, NIU Shihui, LU Zejun, WANG Nana, ZHANG Ling. Effect of irbesartan combined with atorvastatin on C reactive protein and cystatin C of patients with diabetic nephropathy[J]. Journal of Clinical Medicine in Practice, 2017, (21): 33-35. DOI: 10.7619/jcmp.201721009
    [5]ZHANG Shihui, ZHANG Yan, TANG Xi. Effects of hemodialysis combined with hemoperfusion on expression of β2-microglobulin and high-sensitivity C-reactive protein in patients with uremia[J]. Journal of Clinical Medicine in Practice, 2017, (5): 65-67. DOI: 10.7619/jcmp.201705018
    [6]LI Zhi. Changes and diagnostic value of serum procalcitonin and C-reactive protein in patients with severe infection in ICU[J]. Journal of Clinical Medicine in Practice, 2016, (5): 70-72. DOI: 10.7619/jcmp.201605021
    [7]LIU Chijia, CUI Yuntao, ZHANG Aimin. Change and significance of serum procalcitonin and C-reactive protein levels in cerebral hemorrhage patients complicated with infection[J]. Journal of Clinical Medicine in Practice, 2015, (13): 27-29. DOI: 10.7619/jcmp.201513008
    [8]XU Bin, FAN Zhigang, YANG Yun, XU Zongxian. Application of serum procalcitonin and C-reactive protein detections in the diagnosis of neonatal severe infectious disease[J]. Journal of Clinical Medicine in Practice, 2014, (24): 50-52. DOI: 10.7619/jcmp.201424015
    [9]YU Yanhua, LI Junrong, HOU Zhuoran. Influence of atorvastatin on serum visfatin,high-sensitivity C-reactive protein and nitric oxide in patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2014, (23): 5-7. DOI: 10.7619/jcmp.201423002
    [10]ZHOU Lihua. Clinical significance of C-reactive protein and immunoglobulin in cerebrospinal fluid for children infected with meningitis[J]. Journal of Clinical Medicine in Practice, 2013, (16): 123-124,130. DOI: 10.7619/jcmp.201316048

  • Cited by

    Periodical cited type(2)

    1. 于琪力，葛雪，刘丽. 冠状动脉粥样硬化性心脏病患者心力衰竭危险因素分析. 新乡医学院学报. 2024(06): 560-565 .
    2. 孙宁，李飞. 心肌梗死患者血清miR-34a-5p和C1q/肿瘤坏死因子相关蛋白-9水平及其与心肌重构的相关性. 检验医学与临床. 2024(19): 2785-2789 .

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views PDF downloads Cited by(2)
    Turn off MathJax
    Article Contents
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return